Searchable abstracts of presentations at key conferences in endocrinology

ea0031oc4.8 | Obesity, metabolism and bone | SFEBES2013

Peptide YY regulates bone mineral content and strength

Brassill M J , Rahman S A , Boyde A , Batterham R L , Williams G R , Assett J H D B

Bone loss in anorexia nervosa and following bariatric surgery is associated with an elevated circulating concentration of the gastrointestinal anorexigenic hormone peptide YY (PYY), which acts principally via the Y1R and Y2R receptors. Selective deletion of Y1R in osteoblasts or Y2R in the hypothalamus results in high bone mass, but deletion of PYY has resulted in conflicting skeletal phenotypes leading to uncertainty regarding its role in the regulation of bone mass. We hypot...

ea0029p49 | Adrenal cortex | ICEECE2012

Prevalence and Characteristics of Familial Hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino - GENetic forms).

Mulatero P. , Tizzani D. , Viola A. , Monticone S. , Williams T. , Burrello J. , Galmozzi M. , Fulcheri C. , Chiarlo M. , Veglio F.

Primary Aldosteronism (PA) is the most frequent cause of secondary hypertension and patients display an increased prevalence of cardiovascular events compared to essential hypertensives. To date, three familial forms of PA have been described and termed, familial hyperaldosteronism types I, II and III (FH-I to -III). The aim of this study was to investigate the prevalence and clinical characteristics of the three forms of FH in a large population of PA patients. Three hundred ...

ea0025oc1.1 | Young Endocrinologists prize session | SFEBES2011

Thyroid hormones in the euthyroid range predict subsequent body mass composition in women: the OPUS study

Rao Preethi , Williams Graham , Murphy Elaine , Reid David , Roux Christian , Felsenberg Dieter , Gluer Claus , Eastell Richard , Razvi Salman

Background: Thyroid disease is associated with BMI with hyperthyroidism causing weight loss and hypothyroidism leading to weight gain. However, the relation of body weight distribution to thyroid function in euthyroid individuals is unclear. This study assessed body composition in euthyroid women.Methods: Euthyroid women (n=1072) from the Osteoporosis and Ultrasound Study (OPUS), a population based cohort study recruited participants from 5 Europe...

ea0025p154 | Diabetes, metabolism and cardiovascular | SFEBES2011

Over-expression of iodothyronine deiodinase III in the hypothalamic VMN as a potential model of local hypothyroidism

Greenwood Hannah , Counsell John , Richardson Errol , Dhillo Waljit , Boelen Anita , Williams Graham , Bassett Duncan , Bloom Steve , Gardiner James

The hypothalamo-pituitary–thyroid (HPT) axis maintains controlled systemic levels of thyroid hormone (TH). This is achieved through negative feedback via the hypothalamic arcuate and paraventricular nuclei. The effects of thyroid hormone in other hypothalamic nuclei are yet to be elucidated. Administration of triiodothyronine (T3, thyroid hormone) into the hypothalamic ventromedial nucleus (VMN) increases food intake in rats. Thyroid hormone activation and inac...

ea0025p179 | Endocrine tumours and neoplasia | SFEBES2011

Pro-opiomelanocortin is a marker of liver and brain metastases from small cell lung cancer xenografts

Meredith Suzanne , Babur Muhammad , Begum Ghazala , Telfer Brian , Gieling Roben , Dean Emma , Dive Caroline , Williams Kaye , White Anne

Small cell lung cancer (SCLC) is highly aggressive with a particularly poor prognosis. This is due to tumours quickly metastasising and developing chemoresistance. SCLC tumours possess neuroendocrine properties in that they secrete prohormones such as pro-opiomelanocortin (POMC) and pro-gastrin releasing peptide (pro-GRP). These can be detected in the circulation and therefore have potential as biomarkers for prognosis and relapse. The aims of this study are; i) develop a mode...

ea0021p94 | Clinical practice/governance and case reports | SFEBES2009

An evaluation of the knowledge, motivation and weight-management service needs of obese young people

Williams Marc , Kendall Deborah , Gleeson Helena , Amin Rakesh , Banerjee Indi , Ehtisham Sarah , Patel Leena , Clayton Peter , Hall Catherine

Background: Obese young people are likely to suffer significant morbidity in adult life. Successful intervention during adolescence may have far-reaching benefits. Evidence is emerging that patient-responsive clinical services may deliver improved outcomes.Aims: To assess the perceptions of obese young people about weight and weight-management services.Method: Annonymised, postal questionnaire survey of 116 obese young people (9&#1...

ea0015oc33 | Thyroid | SFEBES2008

Effect of thyroid status on the skeleton in post-menopausal women: the OPUS study

Murphy Elaine , Gluer Claus C , Reid David M , Felsenberg Dieter , Roux Christian , Eastell Richard , Williams Graham R

OPUS is a population-based prospective cohort study of post-menopausal women from five European cities. We investigated whether TSH, fT4 and fT3 are associated with fracture risk, bone mineral density (BMD) at hip and spine, bone formation (osteocalcin, procollagen type 1 N-terminal propeptide), bone resorption (N- and C-telopeptides of type 1 collagen, NTX, CTX), pulse rate, grip strength and balance. Vertebral fractures were determined at baseline and 6 years follow-up. Usin...

ea0013p16 | Bone | SFEBES2007

Wnt/β-catenin signalling is abrogated in mice with a targeted mutation in the thyroid hormone receptor (TR) β gene and a thyrotoxic skeletal phenotype

O’Shea Patrick J , Davis Sean , Walker Robert L , Meltzer Paul S , Williams Graham R , Cheng Sheue-yann

Thyroid hormone (T3) is an important regulator of skeletal development and bone turnover. Thyrotoxicosis is associated with accelerated growth, advanced bone age and osteoporosis. T3-action in bone is mediated mainly by T3-receptors (TRs). TRβPV mice harbour a dominant-negative mutation in the TRβ gene that impairs negative feedback control of the hypothalamic-pituitary-thyroid axis resulting in elevated thyroid hormone and TSH concentrations. TRβ<sup...

ea0056ep126 | Pituitary and Neuroendocrinology | ECE2018

Years of Misery: a final resolution ‘panhypopituiatirsm’

Bonner Caoimhe , Grant Bonnie , Hawkins Anna , Lee Yun-ni , Williams Augustine , Chawda Sanjiv , Tanday Raj , Casey Edel , Nikookam Khash

We report a case of a 76 year old gentleman referred to the endocrine department by his general practitioner (GP) with a few years history of severe lethargy, low mood, and dizziness on changing posture. He is known to have hypothyroidism, hypertension, hypercholesterolaemia, benign prostatic hypertrophy, and benign colonic polyps. His medications included amlodipine, finasteride, lansoprazole, atorvastatin and levothyroxine. Examination of all systems were unremarkable, in pa...